Photocure ASA Logo

Photocure ASA

Develops and commercializes photodynamic technology for bladder cancer.

PHO | OL

Overview

Corporate Details

ISIN(s):
NO0010000045
LEI:
5967007LIEEXZXG8OW35
Country:
Norway
Address:
HOFFSVEIEN 4, 0275 OSLO

Description

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-08 08:00
The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonst…
English 214.6 KB
2025-12-08 08:00
The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonst…
English 9.0 KB
2025-11-19 08:00
New budget impact model study in 4 European countries concludes that BLC use of…
English 139.9 KB
2025-11-19 08:00
New budget impact model study in 4 European countries concludes that BLC use of…
English 9.5 KB
2025-10-31 08:25
Photocure ASA: Notification of primary insider transaction - Attachment: 202510…
English 74.7 KB
2025-10-31 08:24
Photocure ASA: Notification of primary insider transaction - Attachment: Releas…
English 107.9 KB
2025-10-31 08:24
Photocure ASA: Notification of primary insider transaction
English 1.4 KB
2025-10-29 07:00
Photocure ASA: Results for the third quarter of 2025 - Attachment: PHO_Q3_2025_…
English 1.6 MB
2025-10-29 07:00
Photocure ASA: Results for the third quarter of 2025 - Attachment: PHO_Q3_2025_…
English 997.3 KB
2025-10-29 07:00
Photocure ASA: Results for the third quarter of 2025 - Attachment: Release.pdf
English 183.0 KB
2025-10-29 07:00
Photocure ASA: Results for the third quarter of 2025
English 6.6 KB
2025-10-24 08:20
Photocure ASA: Invitation to presentation of third quarter 2025 financial resul…
English 2.4 KB
2025-10-15 17:08
Photocure and Intelligent Scopes Corporation partner on development of AI for b…
English 176.1 KB
2025-10-15 17:08
Photocure and Intelligent Scopes Corporation partner on development of AI for b…
English 11.6 KB
2025-09-22 08:23
Photocure ASA - Share option grant - Attachment: 20250922_PHO_Primary_insider_n…
English 110.6 KB

Automate Your Workflow. Get a real-time feed of all Photocure ASA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Photocure ASA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Photocure ASA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT
AVADEL PHARMACEUTICALS PLC Logo
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
United States of America
AVDL
Avalon GloboCare Corp. Logo
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
United States of America
ALBT
Avidity Biosciences, Inc. Logo
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
United States of America
RNA
Axogen, Inc. Logo
Develops and commercializes surgical solutions for peripheral nerve repair.
United States of America
AXGN
Axsome Therapeutics, Inc. Logo
A biopharmaceutical company developing therapies for central nervous system disorders.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
A specialty pharma company developing novel therapeutics for complex CNS diseases.
United States of America
AYTU
Azitra, Inc. Logo
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
United States of America
BRNS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.